Prognostic And Predictive Markers In Hcc

Summary

Based on current trial data, global experts in the management of Panelists Ghassan K. Abou-Alfa, MD; Richard S. Finn, MD; Laura M. Kulik, MD; Riad Salem, MD; and R. Kate Kelley, MD, explore ... Arndt Vogel, MD, and Oliver Waidmann, MD, offer their perspectives on the use of Anuradha S. Budhu, PhD, discusses using molecular features as The panelists, Daniel G. Haller, MD, and Charles S. Fuchs, MD, MPH, provide examples of Pierre Gholam, MD, comments on initial case impressions and Perspectives from Lee Schwartzberg, MD Note: Dr Schwartzberg is a Medical Advisor for Biotheranostics, Inc. Dr Christoph Thomssen - Martin-Luther University, Halle, Germany Dr Thomssen discusses the difficulties faced when developing ... Prof. Greg Gores presents his article " Dr. Stephanie Ma from The University of Hong Kong discusses phenotypic plasticity in primary liver cancer and its effect on ... Emerik Osterlund, MD, PhD, The University of Texas MD Anderson Cancer Center, Houston, TX, discusses the use of circulating ... The research points to a clear strategy for identifying the subset of liver cancer patients who might benefit from treatment with a ... Welcome to KJR SummaryCast—audio summaries of peer-reviewed articles published in the Korean Journal of Radiology.